What a model: A newly developed pancreatic murine cell line permissive to adenoviral replication.
作者信息
Fusciello Manlio, Cerullo Vincenzo
机构信息
Drug Research Program (DRP), ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.
出版信息
Mol Ther Oncol. 2025 Mar 13;33(1):200956. doi: 10.1016/j.omton.2025.200956. eCollection 2025 Mar 20.
Abstract
摘要
相似文献
1
What a model: A newly developed pancreatic murine cell line permissive to adenoviral replication.多么出色的模型：一种新开发的允许腺病毒复制的胰腺小鼠细胞系。
Mol Ther Oncol. 2025 Mar 13;33(1):200956. doi: 10.1016/j.omton.2025.200956. eCollection 2025 Mar 20.
2
KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis.KPC胰腺癌细胞是一种新型的具有免疫活性的小鼠模型，可支持人腺病毒复制和肿瘤溶瘤作用。
Mol Ther Oncol. 2024 Dec 21;33(1):200928. doi: 10.1016/j.omton.2024.200928. eCollection 2025 Mar 20.
3
Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters.人腺病毒在叙利亚仓鼠胰腺癌免疫活性模型中进行复制。
Hum Gene Ther. 2007 Aug;18(8):681-90. doi: 10.1089/hum.2007.017.
4
Effect of adenoviral early genes and the host immune system on in vivo pancreatic gene transfer in the mouse.腺病毒早期基因与宿主免疫系统对小鼠体内胰腺基因转移的影响。
Pancreas. 1997 Oct;15(3):236-45. doi: 10.1097/00006676-199710000-00004.
5
Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.人类腺病毒在体内及不同动物物种原代细胞培养物中的复制特性。
J Virol. 2006 Apr;80(7):3549-58. doi: 10.1128/JVI.80.7.3549-3558.2006.
6
Single-cell transcriptional analysis of murine norovirus infection in a human intestinal cell line.单细胞转录组分析小鼠诺如病毒感染人肠道细胞系。
J Virol. 2024 Nov 19;98(11):e0161724. doi: 10.1128/jvi.01617-24. Epub 2024 Oct 30.
7
Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.生物选择揭示 miR-99b 和 miR-485 可增强胰腺癌细胞中的腺病毒溶瘤作用。
Mol Ther. 2019 Jan 2;27(1):230-243. doi: 10.1016/j.ymthe.2018.09.016. Epub 2018 Sep 27.
8
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.开发一种抗 PD-L1 的叙利亚仓鼠单克隆抗体，使在免疫功能正常、病毒复制允许的环境中进行溶瘤腺病毒免疫治疗建模成为可能。
Front Immunol. 2023 Feb 3;14:1060540. doi: 10.3389/fimmu.2023.1060540. eCollection 2023.
9
Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo.靶向 Ephrin A2 受体不会增加腺病毒在体内对胰腺癌的转导。
World J Gastroenterol. 2009 Jun 14;15(22):2754-62. doi: 10.3748/wjg.15.2754.
10
Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells.热休克蛋白72的表达允许溶瘤腺病毒dl1520（ONYX-015）在大鼠胶质母细胞瘤细胞中进行许可性复制。
Mol Cancer. 2005 Mar 11;4(1):12. doi: 10.1186/1476-4598-4-12.
本文引用的文献
1
An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.用于评估 Delta-24-RGD 溶瘤腺病毒的免疫功能正常、复制允许的叙利亚仓鼠神经胶质瘤模型。
Neuro Oncol. 2021 Nov 2;23(11):1911-1921. doi: 10.1093/neuonc/noab128.
2
Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice.病毒诱导的肿瘤炎症以依赖 Treg 的方式促进了小鼠中有效的 DC 癌症免疫治疗。
J Clin Invest. 2011 Jul;121(7):2570-82. doi: 10.1172/JCI45585. Epub 2011 Jun 6.
3
Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.用 p21/Waf-1 shRNAs 武装 CRAds：新一代溶瘤腺病毒。
Cancer Gene Ther. 2010 Aug;17(8):585-97. doi: 10.1038/cgt.2010.15. Epub 2010 May 7.
4
Armed replicating adenoviruses for cancer virotherapy.用于癌症病毒疗法的武装复制腺病毒
Cancer Gene Ther. 2009 Jun;16(6):473-88. doi: 10.1038/cgt.2009.3. Epub 2009 Feb 6.
5
Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.通过招募和扩增感染端粒酶依赖性溶瘤病毒的肿瘤中的树突状细胞产生抗肿瘤免疫反应。
Cancer Res. 2009 Feb 15;69(4):1448-58. doi: 10.1158/0008-5472.CAN-08-1160. Epub 2009 Feb 3.
6
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.叙利亚仓鼠作为用于溶瘤腺病毒载体研究的允许性免疫活性动物模型。
Cancer Res. 2006 Feb 1;66(3):1270-6. doi: 10.1158/0008-5472.CAN-05-3497.
7
E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models.E3基因操作对免疫健全肿瘤模型中溶瘤腺病毒活性的影响。
Nat Biotechnol. 2003 Nov;21(11):1328-35. doi: 10.1038/nbt887. Epub 2003 Oct 12.
8
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy.用于评估具有复制能力的溶瘤腺病毒疗效的新型免疫活性小鼠肿瘤模型。
Mol Ther. 2003 Sep;8(3):412-24. doi: 10.1016/s1525-0016(03)00199-0.
Zotero 插件